CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 1998 Publications

11-20  21-24

 

1. Reference Ranges for Serum Prostate Specific Antigen (PSA) in Black and White Men Without Cancer.
Weinrich MC, Jacobsen S, Weinrich SP, Moul JW, Oesterling JE, Jacobson D, Wise R:
Urology, 52:967-973, 1998.

 

2. Use of Prostate Specific Antigen in Black Men: Age-Adjusted Reference Ranges for Maximal Cancer Detection.
Moul JW:
J Nat Med Assoc., 90(11-suppl.): 1-2, 1998.

 

3. Treatment Options for Prostate Cancer: Part 1 - Stage, Grade, PSA, and Changes in the 1990's.
Moul JW:
Am J Manage Care, 4:1031-1036, 1998.

 

4. Treatment Options for Prostate Cancer: Part 2 - Early and Late Stage and Hormone Refractory Disease.
Moul JW:
Am J Manage Care. 4:1171-1180, 1998.

 

5. Prostate cancer in African-American men.
Moul JW:
Prostate Cancer and Prost. Dis. 1:109-118, 1998.

 

6. Pelvic Muscle Rehabilitation in Males Following Prostatectomy.
Moul JW:
Urologic Nursing, 18(4): 296-301, 1998.

 

7. Curability of Prostate Cancer in African Americans: Implications for Neoadjuvant/Adjuvant Hormone Therapy.
Moul JW:
Mol. Urol., 2:209-213, 1998.

 

8. Contemporary hormonal management of advanced prostate cancer.
Moul JW:
Oncology 12:499-505, 1998.

 

9. Preoperative and operative factors to predict incontinence, impotence and stricture after radical prostatectomy.
Moul JW, Mooneyhan RM, Kao TC, McLeod DG, Cruess DF:
Prost. Can. Prost Dis., 5:242-249, 1998.

 

10. Metastatic Bone Pain Associated with Prostate Cancer.
Moul JW, Lipo DR:
Home Hlth Care Consult. 5:2-12, 1998.